Asia Pacific Medical Marijuana Market Assessments Report 2020 | Cannabis Sativa, Cara Therapeutics, CannaGrow Holdings, Growbox Sciences, United Cannabis, GreenGro Technologies, Lxaria Crop

Medical marijuana is a type of drug that is used to treat a number of medical conditions such as chronic pain, Alzheimer’s, depression, nausea, cancer, and epilepsy. Since marijuana is a highly addictive drug, governments of several countries have enforced laws to use it. Asia Pacific medical marijuana market is expected to grow at a high rate due to increasing prevalence of chronic diseases and growing awareness regarding the benefits of marijuana.

Get Sample Copy of this Report at https://www.worldwidemarketreports.com/sample/31446

Growing prevalence of chronic diseases such as cancer and Alzheimer’s and increasing therapeutic applications of marijuana plant are the major factors driving growth of the Asia Pacific medical marijuana market. Moreover, rising awareness regarding medicinal benefits of marijuana and increasing authorization of marijuana also contributes to the market growth. For instance, in November 2018, South Korea became the first country in East Asia to legalize cannabis-based medical products.

Disclaimer: The COVID-19 impact analysis is included in the price of the report. Reach out us if you require a standalone chapter.

Get Imapact Analysis - COVID19 at https://www.worldwidemarketreports.com/covidimpact/31446

Rigorous government policies and rising illegal use of marijuana are the factors restraining growth of the Asia Pacific medical marijuana market.

Regional Insights:

Australia dominates the Asia Pacific medical marijuana market due to increasing awareness regarding medicinal benefits of marijuana. South Korea stands second followed by China in the market due to legalization of cannabis-based medical products in South Korea and China being a large producer of legal marijuana. For instance, China grows nearly half of the world’s legal hemp (cannabis that do not contain hallucinogens), according to China’s National Bureau of Statistics.

Competitive Section:

Key players of the Asia Pacific medical marijuana market are Cannabis Sativa, Cara Therapeutics, CannaGrow Holdings, Growbox Sciences, United Cannabis, GreenGro Technologies, Lxaria Crop, GW Pharmaceuticals, and MMJ America.

In August 2019, Growbox Sciences announced medical cannabis products for sale in Louisiana.

In September 2020, GW Pharmaceuticals’ Epidyolex drug received approval from Australia’s Therapeutic Goods Administration.

Place a Direct Purchase order for Complete Report at https://www.worldwidemarketreports.com/buy/31446

Published by Vishal

Contact Us:
Organization: Worldwide Market Reports
Email: sales@worldwidemarketreports.com
Phone: +1 415 871 0703

About Worldwide Market Reports:
The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Reports’ well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

This release was published on openPR.